Key facts
- This page summarizes James C. Hyde's Form 4 filing for BALCHEM CORP (BCPC).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Feb 2022, 08:04.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person.
Footnote F2
Acquired upon the settlement of performance shares granted on February 13, 2019, based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria.
Footnote F3
738 of the 2394 shares that vested February 10, 2022 were withheld to cover withholding taxes due upon vesting.
Footnote F4
Options vest 20% Year 1; 40% Year 2; and 40% Year 3.